Moreover, inhibition of prostate cancer cell growth and tumor growth by amygdalin were evident, revealing a function of the metabolic enzymes betaglucosidase (β-glucosidase) and rhodanese in regulating the anticancer activity of amygdalin in vivo [10]. This evidence concerns the gene TST and prostate carcinoma.